May 17, 2021

Agilex Biolabs’ Toxicology Tapped for SARS-CoV-2 Vaccine Research

ADELAIDE, AUS, May 17, 2021 – (ACN Newswire via SEAPRWire.com) – Agilex Biolabs, Australia’s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials,…

May 7, 2021

Avance Clinical Expands Gene Technology Clinical Trial Services to Meet $17.4 billion Market Demand

ADELAIDE, AUS, May 7, 2021 – (ACN Newswire via SEAPRWire.com) – The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership…

April 30, 2021

Agilex Biolabs Congratulates Bionomics Limited on BNC210 PK Results

ADELAIDE, AUS, Apr 30, 2021 – (ACN Newswire via SEAPRWire.com) – Agilex Biolabs, Australia’s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials,…

April 29, 2021

Agilex Biolabs and B2S Life Sciences on Immunoassay Bioanalysis for Clinical Trials

ADELAIDE, AUS, Apr 29, 2021 – (ACN Newswire via SEAPRWire.com) – Agilex Biolabs, Australia’s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials,…

April 22, 2021

Avance Clinical Invited to Present “Decentralized Trials – No Going Back” for Oracle Health Sciences Connect

ADELAIDE, AU, Apr 22, 2021 – (ACN Newswire via SEAPRWire.com) – The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership…

April 20, 2021

Eisai: 18-Month, Pre-Specified Analysis Showing Consistent Reduction in Clinical Outcome Measures from a Lecanemab (BAN2401) Phase 2b Clinical Trial in Early Alzheimer’s Disease

TOKYO, Apr 20, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and Biogen Inc. today announced the publication of an article, A Randomized,…

March 24, 2021

TOT BIOPHARM Announces A Number of Key Anti-Tumor Drugs Have Entered the Pivotal Clinical Stage in 2020

HONG KONG, Mar 24, 2021 – (ACN Newswire via SEAPRWire.com) – TOT BIOPHARM International Company Limited (“TOT BIOPHARM” or the “Company”; stock code: 1875.HK), a…

March 18, 2021

Agilex Biolabs Showcases Advanced Immunoassay and Immunobiology Services at Bio-Europe Spring 2021

ADELAIDE, AU, Mar 17, 2021 – (ACN Newswire) – Agilex Biolabs, Australia’s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials, today announced it will showcase its…

March 12, 2021

Avance Clinical Client Atossa Therapeutics Announces Final Results from Phase 1 Clinical Study Showing Safety and Tolerability of AT-301 Nasal Spray Being Developed for COVID-19

ADELAIDE, AU, Mar 12, 2021 – (ACN Newswire via SEAPRWire.com) – The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership…

March 9, 2021

Apollomics, Inc. Appoints Seasoned Healthcare Executive K. Peony Yu, M.D., as Chief Medical Officer

Foster City, CA, and Hangzhou, China, Mar 9, 2021 – (ACN Newswire via SEAPRWire.com) – Apollomics, Inc., an innovative biopharmaceutical company committed to the discovery…

February 26, 2021

Avance Clinical and Medidata Celebrate Strategic Partnership and Inhouse Expert Accreditation Milestones

ADELAIDE, AU, Feb 26, 2021 – (ACN Newswire) – The leading Australian CRO for biotechs, and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner,…

February 11, 2021

Novamind Announces Strategic Investment in Bionomics to Support PTSD Clinical Trial

TORONTO, Feb 11, 2021 – (ACN Newswire) – Novamind Inc. (CSE:NM) (“Novamind”), a leading mental health company specialized in psychedelic medicine, is pleased to announce…

February 11, 2021

Apollomics, Inc. and Iterion Therapeutics Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Tegavivint in Greater China

FOSTER CITY, Calif. and HANGZHOU, China and HOUSTON, Texas, Feb 11, 2021 – (ACN Newswire) – Apollomics, Inc., an innovative biopharmaceutical company committed to the…

January 28, 2021

China Biotech Services LY007 Cell Injection Obtained Clinical Trial Approval Letter

HONG KONG, Jan 28, 2021 – (ACN Newswire) – China Biotech Services Holdings Limited (“CH BIOTECH SER” or “Company”, stock code: 8037.HK) non-wholly-owned subsidiary Shanghai…

January 18, 2021

SinoMab Dosed First Healthy Subject in Phase I Clinical Trial of SN1011 in China

HONG KONG, Jan 18, 2021 – (ACN Newswire) – SinoMab BioScience Limited (“SinoMab” or the “Company”, stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated…

January 7, 2021

APL-106 (uproleselan) Granted Breakthrough Therapy Designation in China for the Treatment of Acute Myeloid Leukemia

Foster City, CA, Hangzhou, China, Gaithersburg, MD, Jan 7, 2021 – (ACN Newswire) – Apollomics, Inc., an innovative biopharmaceutical company committed to the discovery and…

October 30, 2020

Avance Clinical Wins MasterControl 2020 Innovation Excellence Award

ADELAIDE, AU, Oct 30, 2020 – (ACN Newswire) – The leading Australian CRO for biotechs, and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award…

October 30, 2020

Agilex Biolabs Client Shasqi Announces Click Chemistry Breakthrough with First-Ever Human Application in Launch of Clinical Program

ADELAIDE, AU, Oct 30, 2020 – (ACN Newswire) – Agilex Biolabs, Australia’s most advanced FDA-inspected specialist bioanalytical laboratory for clinical trials, congratulates client company Shasqi…

October 28, 2020

Eisai to Present Latest Data on Pipeline Assets in the Area of Alzheimer’s Disease and Dementia at the 13th Clinical Trials on Alzheimer’s Disease Conference

TOKYO, Oct 28, 2020 – (JCN Newswire) – Eisai Co., Ltd. announced today that the company will conduct a total of 7 presentations, including the…

October 28, 2020

Biotechs get scalable early to late phase clinical offering from Avance Clinical and Cromos Pharma – announced at Bio-Europe 2020

BIO-Europe, Munich, Oct 28, 2020 – (ACN Newswire) – Two dominant regional contract research organizations (CRO), Avance Clinical and Cromos Pharma, with operations in Australia…